Asian Paints:2,887.90-18.60 (-0.64%)
Cipla:1,535.60+3.52 (+0.23%)
Eicher Motors:6,799.00+103.78 (+1.55%)
Nestle India:1,270.30-1.27 (-0.10%)
Grasim Inds:2,790.30+6.96 (+0.25%)
Hindalco Inds.:807.15+3.54 (+0.44%)
Hind. Unilever:2,425.00-2.67 (-0.11%)
ITC:407.10-1.06 (-0.26%)
Trent:4,404.60+13.61 (+0.31%)
Larsen & Toubro:4,027.70+23.23 (+0.58%)
M & M:3,734.90+36.25 (+0.98%)
Reliance Industr:1,518.30-0.61 (-0.04%)
Tata Consumer:1,178.90+21.07 (+1.82%)
Tata Motors PVeh:372.70-18.50 (-4.73%)
Tata Steel:173.17-1.10 (-0.63%)
Wipro:244.05-0.32 (-0.13%)
Apollo Hospitals:7,487.50+66.79 (+0.90%)
Dr Reddy's Labs:1,244.40-1.62 (-0.13%)
Titan Company:3,868.60+39.44 (+1.03%)
SBI:973.35+5.52 (+0.57%)
Shriram Finance:817.90+8.58 (+1.06%)
Bharat Electron:424.55-2.31 (-0.54%)
Kotak Mah. Bank:2,102.90+23.29 (+1.12%)
Infosys:1,507.60+4.81 (+0.32%)
Bajaj Finance:1,026.80+8.25 (+0.81%)
Adani Enterp.:2,462.00+21.96 (+0.90%)
Sun Pharma.Inds.:1,763.90+6.85 (+0.39%)
JSW Steel:1,175.50+7.71 (+0.66%)
HDFC Bank:996.55+6.93 (+0.70%)
TCS:3,102.20-3.73 (-0.12%)
ICICI Bank:1,379.00+6.04 (+0.44%)
Power Grid Corpn:273.55+2.25 (+0.83%)
Maruti Suzuki:15,878.00+194.48 (+1.24%)
Axis Bank:1,249.60+7.95 (+0.64%)
HCL Technologies:1,606.40+11.80 (+0.74%)
O N G C:248.05+0.45 (+0.18%)
NTPC:330.20+1.74 (+0.53%)
Coal India:387.85+0.89 (+0.23%)
Bharti Airtel:2,112.20+11.55 (+0.55%)
Tech Mahindra:1,452.80+13.53 (+0.94%)
Jio Financial:312.00-2.90 (-0.92%)
Adani Ports:1,507.60-5.14 (-0.34%)
HDFC Life Insur.:770.25-3.48 (-0.45%)
SBI Life Insuran:1,996.00-4.80 (-0.24%)
Max Healthcare:1,121.60+18.53 (+1.68%)
UltraTech Cem.:11,778.00-96.18 (-0.81%)
Bajaj Auto:8,945.50+102.58 (+1.16%)
Bajaj Finserv:2,079.60+13.84 (+0.67%)
Interglobe Aviat:5,873.00-35.45 (-0.60%)
Eternal Ltd:309.55+5.80 (+1.91%)
Asian Paints:2,887.90-18.60 (-0.64%)
Cipla:1,535.60+3.52 (+0.23%)
Eicher Motors:6,799.00+103.78 (+1.55%)
Nestle India:1,270.30-1.27 (-0.10%)
Grasim Inds:2,790.30+6.96 (+0.25%)
Hindalco Inds.:807.15+3.54 (+0.44%)
Hind. Unilever:2,425.00-2.67 (-0.11%)
ITC:407.10-1.06 (-0.26%)
Trent:4,404.60+13.61 (+0.31%)
Larsen & Toubro:4,027.70+23.23 (+0.58%)
M & M:3,734.90+36.25 (+0.98%)
Reliance Industr:1,518.30-0.61 (-0.04%)
Tata Consumer:1,178.90+21.07 (+1.82%)
Tata Motors PVeh:372.70-18.50 (-4.73%)
Tata Steel:173.17-1.10 (-0.63%)
Wipro:244.05-0.32 (-0.13%)
Apollo Hospitals:7,487.50+66.79 (+0.90%)
Dr Reddy's Labs:1,244.40-1.62 (-0.13%)
Titan Company:3,868.60+39.44 (+1.03%)
SBI:973.35+5.52 (+0.57%)
Shriram Finance:817.90+8.58 (+1.06%)
Bharat Electron:424.55-2.31 (-0.54%)
Kotak Mah. Bank:2,102.90+23.29 (+1.12%)
Infosys:1,507.60+4.81 (+0.32%)
Bajaj Finance:1,026.80+8.25 (+0.81%)
Adani Enterp.:2,462.00+21.96 (+0.90%)
Sun Pharma.Inds.:1,763.90+6.85 (+0.39%)
JSW Steel:1,175.50+7.71 (+0.66%)
HDFC Bank:996.55+6.93 (+0.70%)
TCS:3,102.20-3.73 (-0.12%)
ICICI Bank:1,379.00+6.04 (+0.44%)
Power Grid Corpn:273.55+2.25 (+0.83%)
Maruti Suzuki:15,878.00+194.48 (+1.24%)
Axis Bank:1,249.60+7.95 (+0.64%)
HCL Technologies:1,606.40+11.80 (+0.74%)
O N G C:248.05+0.45 (+0.18%)
NTPC:330.20+1.74 (+0.53%)
Coal India:387.85+0.89 (+0.23%)
Bharti Airtel:2,112.20+11.55 (+0.55%)
Tech Mahindra:1,452.80+13.53 (+0.94%)
Jio Financial:312.00-2.90 (-0.92%)
Adani Ports:1,507.60-5.14 (-0.34%)
HDFC Life Insur.:770.25-3.48 (-0.45%)
SBI Life Insuran:1,996.00-4.80 (-0.24%)
Max Healthcare:1,121.60+18.53 (+1.68%)
UltraTech Cem.:11,778.00-96.18 (-0.81%)
Bajaj Auto:8,945.50+102.58 (+1.16%)
Bajaj Finserv:2,079.60+13.84 (+0.67%)
Interglobe Aviat:5,873.00-35.45 (-0.60%)
Eternal Ltd:309.55+5.80 (+1.91%)

Arihant Plus App

Mankind Pharma Ltd

Mankind Pharma | 543904

Market Closed
2,247.00
+0.00 (+-0.89%)
As on 19/11/25, 8:18 AM
Market Cap93,576.48 CR
Current Price₹2,247
High / Low₹3,054.8 / 2,115.1
PE Ratio50.22
Book Value₹347.37
Dividend Yield0.00%
ROCE16.04%
ROE13.89%
Face Value₹2.00
Current Vol.2,92,698
Average Vol.12,76,53,456
ISININE634S01028
PB Ratio6.98
Debt to Equity0.37
Net Profit Margin14.39
Operating Margin26.6
Stock cgart

Stock Performance

2,4802,490
2,500
Previous CloseToday's Open
1,8003,000
2,500
52W Low52W High
₹2,480Today's Open
₹2,490Previous Close
12,00,000Volume
₹1,80052W Low
₹3,00052W High

Ratios

No data available

About Company

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006
  • The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory
  • In 2004, the Company entered the chronic pharmaceutical segment with the launch of Amlokind' tablets and Glimestar' tablets amongst others
  • It set up their first manufacturing facility at Paonta Sahib, in Himachal Pradesh during year 2005
  • It entered the ophthalmic pharmaceutical segment with the launching of Lubistar Eye Drops' and Tobastar Eye Drops'
  • In 2007, the Company diversified into the consumer healthcare segment with the launch of Manforce' brand and have since established several differentiated brands in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral
  • supplements and anti-acne preparations categories
  • It entered into the business of animal healthcare segment and launched Bandykind' and Ceftiforce'
Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI29.56
SMA 202347.33
SMA 502451.00
SMA 1002484.48
SMA 2002446.67
SMA 102266.55
MACD_12_26_Days-62.61
EMA10Day2276.85
EMA20Day2327.81
EMA50Day2407.82
MACD_12_26_9_Days-8.20
EMA100Day2447.73
EMA200Day2454.81

Pivot Points

Volume Analysis

Growth Rate

Revenue Growth18.98%
ROE14.83%
EBITDA Margin26.60%

All figures in ₹ Crores

Indicators20252024202320222021
Revenue
12,207.44
10,260.44
8,749.43
7,781.56
6,214.43
Interest
429.41
32.75
44.47
58.61
20.15
Expenses
9,189.51
7,746.76
6,848.80
5,792.20
4,566.33
Financing Profit
3,566.96
2,809.11
2,041.63
2,199.83
1,830.73
Financing Margin %
29%
27%
23%
28%
29%
Other Income
549.03
295.43
140.99
210.48
182.63
Depreciation
621.22
378.42
325.92
166.62
118.97
Profit before tax
2,516.33
2,397.94
1,671.24
1,974.60
1,691.61
Tax %
20%
19%
22%
26%
24%
Net Profit
2,006.59
1,940.79
1,309.68
1,452.96
1,293.03
EPS in Rs
49.28
47.75
32.00
35.78
31.59
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

DealDateTypeQuantityPriceTraded %
GOLDMAN SACHS BANK EUROPE SE - ODI14 Oct ‘25Purchase55,0002,43012.76%
GOLDMAN SACHS (SINGAPORE) PTE - ODI14 Oct ‘25Sell55,0002,43012.76%
GOLDMAN SACHS BANK EUROPE SE - ODI13 Oct ‘25Purchase42,2452,44020.18%
GOLDMAN SACHS (SINGAPORE) PTE - ODI13 Oct ‘25Sell42,2452,44020.18%
AURIGIN MASTER FUND LIMITED10 Jul ‘24Purchase48,0322,0822.51%
SOCIETE GENERALE10 Jul ‘24Purchase1,20,0782,0826.29%
CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED (ODI)10 Jul ‘24Purchase48,0322,0822.51%
CITIGROUP GLOBAL MARKETS MAURITIUS PVT LTD10 Jul ‘24Purchase96,0632,0825.03%
COPTHALL MAURITIUS INVESTMENT LTD10 Jul ‘24Purchase48,0322,0822.51%
GHISALLO MASTER FUND LP10 Jul ‘24Purchase1,06,0322,0825.55%

News

13 Nov 2025 12:00 am

Volumes soar at SBI Cards & Payment Services Ltd counter

Volumes soar at SBI Cards & Payment Services Ltd counter

Record Date
Corporate Action
Information
Announcement Day
08 Aug 2025
Interim Dividend (₹1)
approved the payment of interim dividend of ? 1/- per equity share i.e. 100% on face value of ? 1/- per equity share for the Financial Year 2025-26 and in terms of Regulation 42 of the Listing Regulations, Board has fixed Friday, August 8, 2025, as the 'Record Date' for the purpose of ascertaining the eligibility of shareholders for payment of interim dividend. Same would be paid within 30 days from the date of declaration.
31 Jul 2025
07 Aug 2025
AGM
AGM
03 Jul 2025
09 Aug 2024
AGM
AGM
18 Jul 2024
22 Sept 2023
AGM
AGM
24 Aug 2023

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
2,224
91,800
53
6
35
0
14.39%
1,760
4,22,211
37
5
30
0
20.88%
6,475
1,71,898
69
11
59
0
23.41%
3,793
1,28,372
59
15
43
1
16.60%
1,515
1,22,349
22
4
19
0
19.21%
1,244
1,03,789
18
3
14
0
17.54%
2,047
93,506
22
5
17
0
14.56%
928
93,404
19
4
15
0
19.86%
1,240
72,630
21
2
14
0
10.98%
5,711
68,288
29
5
25
0
17.09%
Showing 10 of 124 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Map of India background
Couple using investment app

Frequently Asked Questions

What is Share Price of Mankind Pharma Ltd?

The current share price of Mankind Pharma Ltd (Mankind Pharma) is ₹2247.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Mankind Pharma Ltd?

The Price-to-Earnings (P/E) ratio of Mankind Pharma Ltd is 2247.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Mankind Pharma Ltd?

Mankind Pharma Ltd has a 52-week high of ₹3054.80 and a 52-week low of ₹2115.10. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Mankind Pharma Ltd?

Mankind Pharma Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Mankind Pharma Ltd?

The Earnings Per Share (EPS) of Mankind Pharma Ltd is ₹42.36. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Mankind Pharma Ltd?

Mankind Pharma Ltd has a Return on Equity (ROE) of 13.89%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

app store

GET IT ON

Google Play

4.5

app store

DOWNLOAD ON THE

App Store

4.2